In December 2019, a novel coronavirus known as SARS-CoV-2 was first detected in Wuhan,
China, causing outbreaks of the coronavirus disease COVID-19 that has now spread …

In the 2 years since the COVID‐19 pandemic was officially declared, science has made
considerable strides in understanding the disease's pathophysiology, pharmacological …

Accumulating evidence suggests that obesity is a major risk factor for the initiation,
progression, and outcomes of coronavirus disease 2019 (COVID-19). The European …

Obesity is a known risk factor for severe respiratory tract infections. In this prospective study,
we assessed the impact of being obese or overweight on longitudinal SARS-CoV-2 humoral …

An influenza-like virus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-
2) is responsible for COVID-19 disease and spread worldwide within a short time. COVID-19 …

Obesity prevails worldwide to an increasing effect. For example, up to 42% of American
adults are considered obese. Obese individuals are prone to a variety of complications of …

Several hundred studies, 40 systematic reviews, and nearly 20 meta-analyses had been
published by early 2021, confirming an increased need for medical services for people living …

Coronaviruses are constantly circulating in humans, causing common colds and mild
respiratory infections. In contrast, infection with the novel severe acute respiratory syndrome …

Objective Class III obesity (body mass index [BMI]≥ 40 kg m− 2) significantly impairs the
immune response to SARS‐CoV‐2 vaccination. However, the effect of an elevated BMI (≥ …

The coronavirus disease 2019 (COVID-19) is the third known coronavirus after SARS-
coronavirus (SARS-CoV) and middle east respiratory syndrome-coronavirus (MERS-CoV) …